Navigation Links
Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
Date:1/13/2011

ause the final results to differ from these preliminary results.  Finalization of Caliper's financial results for 2010 could lead to revisions in its current expectations regarding revenue for the quarter and year ended December 31, 2010 and for the year ending December 31, 2011.  Further information on risks faced by Caliper is included in risks discussed under the caption "Risk Factors" in Caliper's annual report on Form 10-K for the year ended December 31, 2009, filed with the Securities and Exchange Commission on March 12, 2010, and in our other SEC reports and filings. These SEC reports and filings are available on a web site maintained by the SEC at http://www.sec.gov. Caliper expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Caliper's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.

Reconciliation of GAAP to Non-GAAP Financial MeasuresNon-GAAP Revenues for the Three and Twelve Months Ended December 31, 2010December 31,Three Months EndedTwelve Months Ended2010200920102009(in millions)Unaudited GAAP revenues

$

36.1$

37.7$

123.5$

130.4Effect of divested business operations (1)-4.43.620.1Unaudited Non-GAAP revenues

$

36.1$

33.3$

119.9$

110.3Non-GAAP growth rate8%9%FX impact (fav)/unfav2%1%Organic growth rate10%10%(1) Divested business operations include the sale of the RapidTrace and TurboVap product lines in the second quarter of 2010 and the sale of the Xenogen Biosciences service business in the fourth quarter of 2009.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference
2. Caliper Life Sciences to Present at UBS 2010 Global Life Sciences Conference
3. Caliper Life Sciences Second Quarter 2010 Financial Results Conference Call Notice
4. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
5. Caliper Life Sciences to Webcast Investor Session of Open House
6. Caliper Life Sciences to Present at Jefferies 2010 Global Life Sciences Conference
7. Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage
8. Caliper Awarded Additional Task Order for EPA ToxCast Program
9. Caliper Life Sciences to Present at Deutsche Banks 35th Annual Health Care Conference
10. Caliper Life Sciences Launches LabChip(R) XT for Next Generation Sequencing Applications
11. Caliper Life Sciences Launches Living Image(R) 4.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, ... it has received the second $1.0M tranche under ... Research (SBIR) grant valued at up to $3.0 ... aerosolized KL4 surfactant as a potential medical countermeasure ...  Discovery Labs was awarded an initial $1.0 million ...
(Date:7/29/2015)... , July 30, 2015 According to ... - Growth, Trends & Forecasts (2015-2020), , published by Mordor ... 30.25 billion by the end of 2020, with ... for more than 40% of the global market size. The ... a CAGR of 13.7% during the period of (2015-2020). ...
(Date:7/29/2015)... 2015  AsureQuality and Ubiquitome have agreed to ... in food and primary production sectors. The collaboration ... device, the Freedom4. AsureQuality provides quality ... supermarket shelf for producers, processors and Competent Authorities ... disease control and pest management and surveillance programmes. ...
Breaking Biology Technology:Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
... YORK, May 15 Cadus Corporation (OTC,Bulletin Board: KDUS) announced ... Revenues for the first quarter of 2008 were $100,000, ... for the first quarter of,2008 was $207,996, compared to net ... in net loss can be attributed to a decrease in ...
... BEDFORD, Mass., May 15 Hologic, Inc. (Nasdaq:,HOLX) ... will be,presenting at the Citigroup Investment Research Global ... at the Hilton Hotel in New York,NY., ... live audio webcast of,Hologic,s investor presentation on Thursday, ...
... and BARCELONA, Spain, May 15 Forest,Laboratories, Inc. ... (ALM.MC),will host a webcast to discuss aclidinium bromide ... Thoracic Society Annual Congress.,The webcast, which will include ... on Wednesday, May 21, 2008 at 9:30am New ...
Cached Biology Technology:Cadus Reports First Quarter 2008 Results 2Cadus Reports First Quarter 2008 Results 3Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress 2
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... today announced a series of important changes ... anti-inflammatory class of drugs, including COX-2 selective ... NSAID medications. A list of these products ... , "Today's actions protect and advance the ...
... and life-sustaining series of steps by which hematopoietic stem cells ... white blood cells and platelets has now been discovered to ... This finding, from an investigator at St. Jude Children's Research ... , Mcl-1 blocks the biochemical cascade of reactions that trigger ...
... Massachusetts General Hospital (MGH) has identified 80 new genes ... powerful new research tool for inactivating genes in plants ... find new genes that participate in the gene-silencing mechanism, ... report will appear in the journal Science and is ...
Cached Biology News:FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis 2Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis 3Scientists identify genetic pathways essential to RNA interference 2Scientists identify genetic pathways essential to RNA interference 3
Fingerprinting II comparative quantification and polymorphism analysis is an optional module that adds comparative quantification and polymorphism analysis functions to the Fingerprinting II Basic so...
... Ideal for hand-held applications or for ... II with a hand-held eight-port disposable manifold ... than a multi-channel pipette. The StatMatic II ... bottle sizes and can completely fill a ...
... The DNA Engine Tetrad thermal ... beyond the pioneering PTC-200 DNA Engine ... times the capacity with a footprint ... high throughput for laboratories that run ...
The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....
Biology Products: